We also examined the in vivo inhibitory effects of miyabenol C on β-secretase activity using APP/PS1 transgenic mice, a transgenic mouse model of AD that expresses APP Swedish mutant and PS1 exon-9 deletion mutant. Here, APP is linked to Alzheimer disease.